businesspress24.com - Insys Therapeutics to Present at Upcoming Conferences
 

Insys Therapeutics to Present at Upcoming Conferences

ID: 1285262

(firmenpresse) - PHOENIX, AZ -- (Marketwired) -- 11/20/13 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the Company will present at the following upcoming investor conferences:

The 25th Annual Piper Jaffray Healthcare Conference taking place at The New York Palace on December 3-4, 2013 in New York City. Management is scheduled to present on Tuesday, December 3, 2013 at 2:30 p.m. EST.

The 24th Annual Oppenheimer Healthcare Conference taking place at the Crowne Plaza Hotel on December 10-11, 2013 in New York City. Management is scheduled to present on Tuesday, December 10, 2013 at 3:55 p.m. EST.

During these presentations, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of these presentations during the event, please visit: . A replay of each webcast will be available for 30 days after the initial presentation.

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products, with a focus on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products. The company has two marketed products including Subsys, a proprietary sublingual fentanyl spray for breakthrough pain in opioid-tolerant cancer patients. Insys markets Subsys through its incentive-based, cost-efficient commercial sales force. The company's lead product candidate is Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol, which would be its second branded supportive care product, if approved.



Darryl S. Baker
Chief Financial Officer
Insys Therapeutics, Inc.
602-910-2617

Lisa M. Wilson
President
In-Site Communications, Inc.
212-452-2793




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa
Bereitgestellt von Benutzer: Marketwired
Datum: 20.11.2013 - 07:00 Uhr
Sprache: Deutsch
News-ID 1285262
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

PHOENIX, AZ


Phone:

Kategorie:

Drugs


Anmerkungen:


Diese Pressemitteilung wurde bisher 136 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Insys Therapeutics to Present at Upcoming Conferences
"
steht unter der journalistisch-redaktionellen Verantwortung von

Insys Therapeutics (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Insys Therapeutics



 

Who is online

All members: 10 564
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 77


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.